Buti, S., Donini, M., Bersanelli, M., Gattara, A., Leonardi, F., & Passalacqua, R. (2017). Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study. Drugs R D.
Čikaški stil citiranjaButi, Sebastiano, Maddalena Donini, Melissa Bersanelli, Alessia Gattara, Francesco Leonardi, i Rodolfo Passalacqua. "Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients With Metastatic Renal Cell Carcinoma: A Retrospective Study." Drugs R D 2017.
MLA način citiranjaButi, Sebastiano, et al. "Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients With Metastatic Renal Cell Carcinoma: A Retrospective Study." Drugs R D 2017.